{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T03:07:12Z","timestamp":1788836832574,"version":"build-2803163510"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["GLD21-00121"],"award-info":[{"award-number":["GLD21-00121"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"GILEAD Fellowship Program Spain"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Ongoing high-risk behaviors continue to fuel HCV transmission among men who have sex with men (MSM), challenging elimination efforts. We studied HCV epidemiology in MSM with HIV (MSM-WH) and without HIV in the region of Madrid.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This prospective study (2022\u20132024) enrolled MSM-WH from 10 centers and MSM on PrEP from an STI clinic. Visits were scheduled at baseline, 3, 6, 9, and 12 months (PrEP group), or baseline, 6, and 12 months (HIV group). Assessments included liver enzymes, HCV serology, HCV-RNA, and STI screening (syphilis, chlamydia, and gonorrhea by PCR).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 1372 MSM (733 with HIV; 639 on PrEP) were enrolled. Baseline HCV prevalence was 1.68%, significantly higher in those with prior HCV exposure (5.60% vs 0.72%; prevalence ratio: 7.72, 95% CI: 3.31\u201318.03). Over 1240.4 person-years (PY) of follow-up, overall HCV incidence was 1.45\/100 PY. Primary infection incidence was 0.79\/100 PY: 0.94 in PrEP users versus 0.65 in MSM-WH (IRR: 1.44, 95% CI: .24\u20139.80). Reinfection incidence was 4.32\/100 PY overall: 12.90 in PrEP users and 4.05 in MSM-WH (IRR: 3.21, 95% CI: .07\u201322.53). Two participants experienced within study reinfection (8.7\/100 PY, 95% CI: 1.05\u201331.4). Slamsex and condomless receptive anal intercourse with \u22654 partners were independently associated with HCV infection and reinfection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>MSM with prior HCV exposure had markedly higher HCV prevalence and incidence, regardless of HIV status. Risky sexual behaviors remain key drivers of HCV transmission. Behavior-informed prevention strategies are critical to sustain elimination efforts in MSM populations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ofid\/ofaf678","type":"journal-article","created":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T07:48:42Z","timestamp":1762674522000},"source":"Crossref","is-referenced-by-count":3,"title":["Epidemiology and Risk Factors for HCV Infection Among MSM With or at Risk of HIV in Madrid (2022\u20132024)"],"prefix":"10.1093","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4212-7419","authenticated-orcid":false,"given":"Pablo","family":"Ryan","sequence":"first","affiliation":[{"name":"Enfermedades Infecciosas, Hospital Universitario Infanta Leonor , Madrid ,","place":["Spain"]},{"name":"Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n (IiSGM) , Madrid ,","place":["Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC) , Madrid ,","place":["Spain"]},{"name":"Universidad Complutense de Madrid (UCM) , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8541-8200","authenticated-orcid":false,"given":"Juan","family":"Berenguer","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n (IiSGM) , Madrid ,","place":["Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC) , Madrid ,","place":["Spain"]},{"name":"Unidad de Enfermedades Infecciosas, Hospital General Universitario Gregorio Mara\u00f1\u00f3n , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5251-2161","authenticated-orcid":false,"given":"Luis","family":"Ramos-Ruperto","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC) , Madrid ,","place":["Spain"]},{"name":"Unidad de VIH\/Servicio de Medicina Interna, Hospital Universitario La Paz , Madrid ,","place":["Spain"]},{"name":"Instituto de Investigaci\u00f3n Sanitaria Hospital La Paz (IdiPAZ) , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar","family":"Vera","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC) , Madrid ,","place":["Spain"]},{"name":"Centro Sanitario Sandoval , Madrid ,","place":["Spain"]},{"name":"Enfermedades Infecciosas, Hospital Cl\u00ednico San Carlos , Madrid ,","place":["Spain"]},{"name":"Instituto de Investigaci\u00f3n Sanitaria del Hospital Cl\u00ednico de San Carlos (IdISSC) , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luz","family":"Mart\u00edn-Carbonero","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC) , Madrid ,","place":["Spain"]},{"name":"Unidad de VIH\/Servicio de Medicina Interna, Hospital Universitario La Paz , Madrid ,","place":["Spain"]},{"name":"Instituto de Investigaci\u00f3n Sanitaria Hospital La Paz (IdiPAZ) , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leire","family":"P\u00e9rez-Latorre","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n (IiSGM) , Madrid ,","place":["Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC) , Madrid ,","place":["Spain"]},{"name":"Unidad de Enfermedades Infecciosas, Hospital General Universitario Gregorio Mara\u00f1\u00f3n , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7073-5211","authenticated-orcid":false,"given":"Ignacio","family":"De los Santos","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC) , Madrid ,","place":["Spain"]},{"name":"Enfermedades Infecciosas, Hospital Universitario de la Princesa , Madrid ,","place":["Spain"]},{"name":"Instituto de Investigaci\u00f3n Sanitaria del Hospital de la Princesa (IIS-PRINCESA) , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Pinto","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC) , Madrid ,","place":["Spain"]},{"name":"Unidad VIH, Hospital Universitario 12 de Octubre , Madrid ,","place":["Spain"]},{"name":"Instituto de Investigaci\u00f3n Sanitaria Hospital 12 de Octubre (I+12) , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9373-6011","authenticated-orcid":false,"given":"Mar\u00eda J","family":"Vivancos","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC) , Madrid ,","place":["Spain"]},{"name":"Enfermedades Infecciosas, Hospital Universitario Ram\u00f3n y Cajal , Madrid ,","place":["Spain"]},{"name":"Instituto Ram\u00f3n y Cajal de Investigaci\u00f3n Sanitaria (IRYCIS) , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2684-3431","authenticated-orcid":false,"given":"Eva","family":"Orviz","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC) , Madrid ,","place":["Spain"]},{"name":"Enfermedades Infecciosas, Hospital Cl\u00ednico San Carlos , Madrid ,","place":["Spain"]},{"name":"Instituto de Investigaci\u00f3n Sanitaria del Hospital Cl\u00ednico de San Carlos (IdISSC) , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"\u00c1lvarez","sequence":"additional","affiliation":[{"name":"Enfermedades Infecciosas, Hospital Universitario Fundaci\u00f3n Jim\u00e9nez D\u00edaz , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Sanz","sequence":"additional","affiliation":[{"name":"Enfermedades Infecciosas, Hospital Universitario Pr\u00edncipe de Asturias , Alcal\u00e1 de Henares ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Ruiz-Seco","sequence":"additional","affiliation":[{"name":"Medicina Interna, Hospital Universitario Infanta Sof\u00eda (FIIB HUIS-HUHEN) , San Sebasti\u00e1n de los Reyes ,","place":["Spain"]},{"name":"Universidad Europea de Madrid , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Torres","sequence":"additional","affiliation":[{"name":"Enfermedades Infecciosas, Hospital Universitario Severo Ochoa , Legan\u00e9s ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Brazal","sequence":"additional","affiliation":[{"name":"Fundaci\u00f3n SEIMC-GeSIDA , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"De Miguel","sequence":"additional","affiliation":[{"name":"Fundaci\u00f3n SEIMC-GeSIDA , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3575-3008","authenticated-orcid":false,"given":"Beatriz","family":"L\u00f3pez-Centeno","sequence":"additional","affiliation":[{"name":"Subdirecci\u00f3n General de Farmacia y Productos Sanitarios, Servicio Madrile\u00f1o de Salud (SERMAS) , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inmaculada","family":"Jarr\u00edn","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC) , Madrid ,","place":["Spain"]},{"name":"Centro Nacional de Epidemiolog\u00eda\u2014Instituto de Salud Carlos III (ISCIII) , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8783-0450","authenticated-orcid":false,"given":"Salvador","family":"Resino","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC) , Madrid ,","place":["Spain"]},{"name":"Centro Nacional de Microbiolog\u00eda\u2014Instituto de Salud Carlos III (ISCIII) , Majadahonda ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8492-1565","authenticated-orcid":false,"given":"Jos\u00e9 M","family":"Bell\u00f3n","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n (IiSGM) , Madrid ,","place":["Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC) , Madrid ,","place":["Spain"]},{"name":"Unidad de Enfermedades Infecciosas, Hospital General Universitario Gregorio Mara\u00f1\u00f3n , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Gonz\u00e1lez-Garc\u00eda","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC) , Madrid ,","place":["Spain"]},{"name":"Unidad de VIH\/Servicio de Medicina Interna, Hospital Universitario La Paz , Madrid ,","place":["Spain"]},{"name":"Instituto de Investigaci\u00f3n Sanitaria Hospital La Paz (IdiPAZ) , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,11,6]]},"reference":[{"key":"2025112612183061300_ofaf678-B1","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0016-5085(83)90336-0","article-title":"Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features","volume":"85","author":"Dienstag","year":"1983","journal-title":"Gastroenterology"},{"key":"2025112612183061300_ofaf678-B2","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1056\/NEJM199908193410802","article-title":"The prevalence of hepatitis C virus infection in the United States, 1988 through 1994","volume":"341","author":"Alter","year":"1999","journal-title":"N Engl J Med"},{"key":"2025112612183061300_ofaf678-B3","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.3851\/IMP2459","article-title":"Transfusion transmission of HCV, a long but successful road map to safety","volume":"17","author":"Selvarajah","year":"2012","journal-title":"Antivir Ther"},{"key":"2025112612183061300_ofaf678-B4","volume-title":"Global hepatitis report 2024: action for access in low- and middle-income countries","author":"World Health Organization","year":"2024"},{"key":"2025112612183061300_ofaf678-B5","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1097\/01.aids.0000171412.61360.f8","article-title":"A cluster of acute hepatitis C virus infection among men who have sex with men\u2013results from contact tracing and public health implications","volume":"19","author":"Gotz","year":"2005","journal-title":"AIDS"},{"key":"2025112612183061300_ofaf678-B6","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1097\/QAD.0000000000002622","article-title":"Recently acquired and early chronic hepatitis C in MSM: recommendations from the European treatment network for HIV, hepatitis and global infectious diseases consensus panel","volume":"34","year":"2020","journal-title":"AIDS"},{"key":"2025112612183061300_ofaf678-B7","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1136\/sextrans-2012-050566","article-title":"Incidence of acute hepatitis C virus infection among men who have sex with men with and without HIV infection: a systematic review","volume":"88","author":"Yaphe","year":"2012","journal-title":"Sex Transm Infect"},{"key":"2025112612183061300_ofaf678-B8","doi-asserted-by":"crossref","first-page":"ofad401","DOI":"10.1093\/ofid\/ofad401","article-title":"Incidence and prevalence of hepatitis C virus among HIV-negative gay and bisexual men using HIV Pre-exposure prophylaxis (PrEP): a systematic review and meta-analysis","volume":"10","author":"Traeger","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"2025112612183061300_ofaf678-B9","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1056\/NEJMe1403619","article-title":"Therapy of hepatitis C\u2013back to the future","volume":"370","author":"Liang","year":"2014","journal-title":"N Engl J Med"},{"key":"2025112612183061300_ofaf678-B10","volume-title":"Global hepatitis report 2017","author":"World Health Organization","year":"2017"},{"key":"2025112612183061300_ofaf678-B11","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1002\/hep.32237","article-title":"Favorable impact in hepatitis C-related mortality following free access to direct-acting antivirals in Spain","volume":"75","author":"Politi","year":"2022","journal-title":"Hepatology"},{"key":"2025112612183061300_ofaf678-B12","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/jvh.13708","article-title":"Hepatitis C hospitalizations in Spain and impact of new curative antiviral therapies","volume":"29","author":"Ramos-Rincon","year":"2022","journal-title":"J Viral Hepat"},{"key":"2025112612183061300_ofaf678-B13","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/HEP.0000000000000779","article-title":"Feasibility of hepatitis C elimination by screening and treatment alone in high-income countries","volume":"80","author":"Tian","year":"2024","journal-title":"Hepatology"},{"key":"2025112612183061300_ofaf678-B14","doi-asserted-by":"crossref","first-page":"ofy154","DOI":"10.1093\/ofid\/ofy154","article-title":"Impact of direct-acting antivirals on the burden of HCV infection among persons who inject drugs and men who have sex with men in the Swiss HIV cohort study","volume":"5","author":"Salazar-Vizcaya","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"2025112612183061300_ofaf678-B15","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/QAD.0000000000002103","article-title":"Reinfection by hepatitis C virus following effective all-oral direct-acting antiviral drug therapy in HIV\/hepatitis C virus coinfected individuals","volume":"33","author":"Berenguer","year":"2019","journal-title":"AIDS"},{"key":"2025112612183061300_ofaf678-B16","doi-asserted-by":"crossref","first-page":"e1056","DOI":"10.1093\/cid\/ciaa1830","article-title":"Hepatitis C virus transmission among men who have sex with men in Amsterdam: external introductions may complicate microelimination efforts","volume":"72","author":"Koopsen","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2025112612183061300_ofaf678-B17","doi-asserted-by":"crossref","first-page":"101810","DOI":"10.1016\/j.eclinm.2022.101810","article-title":"Treatment as prevention effect of direct-acting antivirals on primary hepatitis C virus incidence: findings from a multinational cohort between 2010 and 2019","volume":"56","author":"van Santen","year":"2023","journal-title":"EClinicalMedicine"},{"key":"2025112612183061300_ofaf678-B18","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/S2352-3018(23)00267-9","article-title":"Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010\u201319: an analysis of data from a consortium of prospective cohort studies","volume":"11","author":"Sacks-Davis","year":"2024","journal-title":"Lancet HIV"},{"key":"2025112612183061300_ofaf678-B19","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.eimc.2011.06.002","article-title":"The cohort of the Spanish HIV Research Network (CoRIS) and its associated biobank; organizational issues, main findings and losses to follow-up","volume":"29","author":"Sobrino-Vegas","year":"2011","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"2025112612183061300_ofaf678-B20","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.29814","article-title":"All-oral direct-acting antiviral therapy against hepatitis C virus (HCV) in human immunodeficiency virus\/HCV-coinfected subjects in real-world practice: madrid coinfection registry findings","volume":"68","author":"Berenguer","year":"2018","journal-title":"Hepatology"},{"key":"2025112612183061300_ofaf678-B21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.eimc.2024.03.014","article-title":"Pre-exposure prophylaxis program in the community of Madrid: two years of experience","volume":"43","author":"Fernandez Pineiro","year":"2025","journal-title":"Enferm Infecc Microbiol Clin (Engl Ed)"},{"key":"2025112612183061300_ofaf678-B22","doi-asserted-by":"crossref","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"key":"2025112612183061300_ofaf678-B23","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S2468-1253(20)30303-4","article-title":"Prevalence and incidence of hepatitis C virus infection in men who have sex with men: a systematic review and meta-analysis","volume":"6","author":"Jin","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025112612183061300_ofaf678-B24","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1111\/liv.15237","article-title":"Prevalence and incidence of hepatitis C infection amongst men who have sex with men in a population-based pre-exposure prophylaxis program in British Columbia, Canada","volume":"42","author":"Thompson","year":"2022","journal-title":"Liver Int"},{"key":"2025112612183061300_ofaf678-B25","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/jvh.13678","article-title":"Low incidence and prevalence of hepatitis C in two cohorts of HIV pre-exposure prophylaxis adherence interventions in men who have sex with men in Southern California","volume":"29","author":"Hassan","year":"2022","journal-title":"J Viral Hepat"},{"key":"2025112612183061300_ofaf678-B26","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jhep.2019.11.022","article-title":"High incidence of HCV in HIV-negative men who have sex with men using pre-exposure prophylaxis","volume":"72","author":"Hoornenborg","year":"2020","journal-title":"J Hepatol"},{"key":"2025112612183061300_ofaf678-B27","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1111\/liv.13922","article-title":"Hepatitis C virus incidence in HIV-infected and in preexposure prophylaxis (PrEP)-using men having sex with men","volume":"38","author":"Cotte","year":"2018","journal-title":"Liver Int"},{"key":"2025112612183061300_ofaf678-B28","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1093\/cid\/ciab720","article-title":"The incidence of hepatitis C among gay, bisexual, and other men who have sex with men in Australia, 2009\u20132019","volume":"74","author":"Harney","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2025112612183061300_ofaf678-B29","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1093\/cid\/ciae297","article-title":"Hepatitis C virus reinfection among men who have sex with men with HIV in New York city","volume":"79","author":"Fierer","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2025112612183061300_ofaf678-B30","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1093\/cid\/ciz949","article-title":"Reinfection with the hepatitis C virus in men who have sex with men after successful treatment with direct-acting antivirals in Germany: current incidence rates, compared with rates during the interferon era","volume":"71","author":"Ingiliz","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2025112612183061300_ofaf678-B31","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/hiv.13651","article-title":"Recently acquired HCV infection in men who have sex with men in Germany in the direct-acting antivirals era and during the COVID-19 pandemic","volume":"25","author":"Ingiliz","year":"2024","journal-title":"HIV Med"},{"key":"2025112612183061300_ofaf678-B32","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1093\/cid\/ciz160","article-title":"Patterns of hepatitis C virus transmission in human immunodeficiency virus (HIV)-infected and HIV-negative men who have sex with men","volume":"69","author":"Ramiere","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2025112612183061300_ofaf678-B33","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/jvh.13286","article-title":"Transmission of hepatitis C virus in HIV-positive and PrEP-using MSM in England","volume":"27","author":"Bradshaw","year":"2020","journal-title":"J Viral Hepat"},{"key":"2025112612183061300_ofaf678-B34","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/cid\/ciaa645","article-title":"Incidence of HCV reinfection among HIV-positive MSM and its association with sexual risk behavior: a longitudinal analysis","volume":"73","author":"Newsum","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2025112612183061300_ofaf678-B35","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1097\/QAD.0000000000003651","article-title":"Reinfection incidence and risk among people treated for recent hepatitis C virus infection","volume":"37","author":"Martinello","year":"2023","journal-title":"AIDS"},{"key":"2025112612183061300_ofaf678-B36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","article-title":"Sexually transmitted infections treatment guidelines, 2021","volume":"70","author":"Workowski","year":"2021","journal-title":"MMWR Recomm Rep"},{"key":"2025112612183061300_ofaf678-B37","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S2468-1253(25)00068-8","article-title":"A 2024 global report on national policies, programmes, and progress towards hepatitis C elimination: findings from 33 hepatitis elimination profiles","volume":"10","author":"Hiebert-Suwondo","year":"2025","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025112612183061300_ofaf678-B38","first-page":"e202510056","article-title":"10 years of the strategic plan for tackling hepatitis C in the Spanish national health system (PEAHC): a national project for the elimination of hepatitis C as a public health problem","volume":"99","author":"Del Amo Valero","year":"2025","journal-title":"Rev Esp Salud Publica"},{"key":"2025112612183061300_ofaf678-B39","doi-asserted-by":"publisher","first-page":"ciaf407","DOI":"10.1093\/cid\/ciaf407","article-title":"Trends in HCV infection prevalence among people with HIV in Spain over two decades (2002\u20132023)","author":"Berenguer","year":"2025","journal-title":"Clin Infect Dis"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofaf678\/65238150\/ofaf678.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/12\/12\/ofaf678\/65238150\/ofaf678.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/12\/12\/ofaf678\/65238150\/ofaf678.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T17:18:43Z","timestamp":1764177523000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofaf678\/8316291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":39,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,11,26]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofaf678","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,12]]},"published":{"date-parts":[[2025,11,6]]},"article-number":"ofaf678"}}